Recruiting studies: Vexas Syndrome

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

AutoInflammatory Disease Alliance Registry (AIDA)
Phase N/A · 112 location(s) · University of Siena · NCT05200715 A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
Phase 2 · 39 location(s) · Swedish Orphan Biovitrum · NCT06782373 Autoimmune and Autoinflammatory Genetics Study
Phase N/A · 2 location(s) · NYU Langone Health · NCT06004349 A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT05027945 HRQoL and Financial Toxicity in Patients With VEXAS Syndrome
Phase N/A · 17 location(s) · Gruppo Italiano Malattie EMatologiche dell'Adulto · NCT06657846 Multicenter, Interdisciplinary National VEXAS Registry With Accompanying Biomaterial Collection
Phase N/A · 17 location(s) · Technische Universität Dresden · NCT06377462 Pacritinib in Vacuoles, E1 Ubiqutin-activating Enzyme, X-linked, Autoinflammatory, Somatic (VEXAS) Syndrome
Phase 1 · 1 location(s) · Washington University School of Medicine · NCT06538181 Momelotinib in VEXAS Syndrome
Phase 2 · 11 location(s) · Groupe Francophone des Myelodysplasies · NCT07098936

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.